Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.

Male hormones affect oil-producing skin cells differently based on their body location, and the drug spironolactone can reduce these effects.

Treat hair loss with finasteride, minoxidil, or surgery; consider side effects and severity.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Spironolactone may help reduce excessive hair growth in women with high male hormone levels.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

More pediatric-specific research and guidelines are needed to improve hidradenitis suppurativa treatment in children and adolescents.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Manage hair shedding by identifying triggers, possibly using supplements or medications, and tracking with a health calendar.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Severe insulin resistance can be managed with medication, lifestyle changes, and treatment for related conditions.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Cyproterone acetate effectively treats sexual disorders by reducing sexual functions and is generally well-tolerated.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Flutamide improves female hair loss when other treatments fail, but may cause liver toxicity.

The conclusion is that the best approach for treating Female Pattern Hair Loss is a combination of different treatments.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Some medications can reduce excessive hair growth in women, but more research is needed to find the best treatment combinations.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Finasteride reduces hirsutism effectively with fewer side effects but is a second-choice treatment due to safety concerns.

Certain medications and maintaining adequate iron levels can help manage women's hair loss.

Human skin cells contain Protease Nexin-1, and male hormones can decrease its levels, potentially affecting hair growth.